161
Views
14
CrossRef citations to date
0
Altmetric
Perspective

Application of amniotic membrane in reconstructive urology; the promising biomaterial worth further investigation

, , , &
Pages 9-24 | Received 04 Apr 2018, Accepted 03 Dec 2018, Published online: 17 Dec 2018

References

  • Niknejad H, Peirovi H, Jorjani M, et al. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater. 2008;15:88–99.
  • Tseng SC, Prabhasawat P, Lee SH, et al. Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol. 1997;124:14765–14774.
  • Zeng B, Wang P, Xu LJ, et al. Amniotic membrane covering promotes healing of cornea epithelium and improves visual acuity after debridement for fungal keratitis. Int J Ophthalmol. 2014;18:785–789.
  • Baradaran-Rafii A, Biazar E, Heidari-Keshel S. Cellular response of limbal stem cells on polycaprolactone nanofibrous scaffolds for ocular epithelial regeneration. Curr Eye Res. 2015;21:1–8.
  • Adamowicz J, Kowalczyk T, Drewa T. Tissue engineering of urinary bladder – current state of art and future perspectives. Cent European J Urol. 2013;66:202–206.
  • Oligny LL. Human molecular embryogenesis: an overview. Pediatr Dev Pathol. 2001;4:324–343.
  • Kay HD, Michael Nelson MD, Wang Y. The placenta: from development to disease. Chichester: Wiley-Blackwell; 2011.
  • Favaron PO, Carvalho RC, Borghesi J, et al. The amniotic membrane: development and potential applications. Reprod Domest Anim. 2015;50:881–892.
  • Riboh JC, Saltzman BM, Yanke AB, et al. Human amniotic membrane-derived products in sports medicine: basic science, early results, and potential clinical applications. Am J Sports Med. 2016;44:2425–2434.
  • Toda A, Okabe M, Yoshida T, et al. The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. J Pharmacol Sci. 2007;105:215–228.
  • Gupta A, Kedige SD, Jain K. Amnion and chorion membranes: potential stem cell reservoir with wide applications in periodontics. Int J Biomater. 2015;2015:274–282.
  • Dietrich-Ntoukas T, Hofmann-Rummelt C, Kruse FE, et al. Comparative analysis of the basement membrane composition of the human limbus epithelium and amniotic membrane epithelium. Cornea. 2012;31:564–569.
  • Mamede AC, Carvalho MJ, Abrantes AM, et al. Amniotic membrane: from structure and functions to clinical applications. Cell Tissue Res. 2012;349:447–458.
  • Parolini O, Alviano F, Bagnara GP, et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells. 2008;26:300–311.
  • Priddy LJ, Lim JJ, Koob TJ. Dehydrated Human Amnion/Chorion Membrane (dHACM) allografts as a therapy for orthopedic tissue repair. Tech Orthopaedics. 2017;32:149–157.
  • Jirsova K, Jones GLA. Amniotic membrane in ophthalmology: properties, preparation, storage and indications for grafting. Cell Tissue Bank. 2017;18:193–204.
  • Forsten-Williams K, Chu CL, Fannon M, et al. Control of growth factor networks by heparan sulfate proteoglycans. Ann Biomed Eng. 2008;36:2134–2148.
  • Hopkinson A1, McIntosh RS, Tighe PJ, et al. Amniotic membrane for ocular surface reconstruction: donor variations and the effect of handling on TGF-beta content. Invest Ophthalmol Vis Sci. 2006;47:1622–1643.
  • Koizumi NJ, Inatomi TJ, Sotozono CJ, et al. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res. 2000;20:173–177.
  • Hao Y, Ma DH, Hwang DG, et al. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea. 2000;19:348–352.
  • Mohan R, Bajaj A, Gundappa M. Human amnion membrane: potential applications in oral and periodontal field. J Int Soc Prev Community Dentz. 2017;7:15–21.
  • Rossi D, Pianta S, Magatti M, et al. Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity. PLoS One. 2012;7:e46956.
  • Yamahara K, Harada K, Ohshima M, et al. Comparison of angiogenic, cytoprotective, and immunosuppressive properties of human amnion- and chorion-derived mesenchymal stem cells. PLoS One. 2014;9:e88319.
  • Himmura S, Shimazaki J, Ohashi Y, et al. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea. 2001;20:408–413.
  • Hortensius RA, Ebens JH, Harley BA. Immunomodulatory effects of amniotic membrane matrix incorporated into collagen scaffolds. J Biomed Mater Res A. 2016;104:1332–1342.
  • Solomon A, Wajngarten M, Alviano F, et al. Suppression of inflammatory and fibrotic responses in allergic inflammation by the amniotic membrane stromal matrix. Clin Exp Allergy. 2005;35:941–948.
  • Li H, Niederkorn JY, Neelam S, et al. Immunosuppressive factors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci. 2005;46:900–907.
  • Li W, He H, Kawakita T, et al. Amniotic membrane induces apoptosis of interferon-gamma activated macrophages in vitro. Exp Eye Res. 2006;82:282–292.
  • Sant’Anna LB, Brito FS, Barja PR, et al. Long-term effects of human amniotic membrane in a rat model of biliary fibrosis. Braz J Med Biol Res. 2017;50:e5692.
  • Frangouli O, Adams GG. The use of amniotic membrane for the management of fibrosis complex strabismus surgery. Strabismus. 2013;21:13–22.
  • Peirovi H, Rezvani N, Hajinasrollah M, et al. Implantation of amniotic membrane as a vascular substitute in the external jugular vein of juvenile sheep. J Vasc Surg. 2012;56:1098–1104.
  • Cargnoni A, Piccinelli EC, Ressel L, et al. Conditioned medium from amniotic membrane-derived cells prevents lung fibrosis and preserves blood gas exchanges in bleomycin-injured mice-specificity of the effects and insights into possible mechanisms. Cytotherapy. 2014;16:17–32.
  • Ricci E, Vanosi G, Lindenmair A, et al. Anti-fibrotic effects of fresh and cryopreserved human amniotic membrane in a rat liver fibrosis model. Cell Tissue Bank. 2013;14:475–488.
  • Cotton SA, Gbadegesin RA, Williams S, et al. Role of TGF-beta1 in renal parenchymal scarring following childhood urinary tract infection. Kidney Int. 2002;61:61–67.
  • Kawakita T, Espana EM, He H, et al. Preservation and expansion of the primate keratocyte phenotype by downregulating TGF-beta signaling in a low-calcium, serum-free medium. Invest Ophthalmol VisSci. 2006;47:1918–1927.
  • Kobayashi K, Umezawa K, Yasui M. Apoptosis in mouse amniotic epithelium isinduced by activated macrophages through the TNF receptor type 1/TNF pathway. Biol Reprod. 2011;84:248–254.
  • Zeng W, Li Y, Zeng G, et al. Transplantation with cultured stem cells derived from the human amniotic membrane for corneal alkali burns: anexperimental study. Ann Clin Lab Sci. 2014;44:73–81.
  • SantAnna LB, Hage R, Cardoso MA, et al. Antifibrotic effects of human amniotic membrane transplantation inestablished biliary fibrosis induced in rats. Cell Transplant. 2016;25:2245–2257.
  • Li W, He H, Chen YT, et al. Reversal of myofibroblasts by amniotic membrane stromal extract. J Cell Physiol. 2008;215:657–664.
  • Koizumi N, Fullwood NJ, Bairaktaris G, et al. Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane. Invest Ophthalmol Vis Sci. 2000;41:2506–2513.
  • Kubo M, Sonoda Y, Muramatsu R, et al. Immunogenicity of human amnioticmembrane in experimental xenotransplantation. Invest Ophthalmol Vis Sci. 2001;42:1539–1546.
  • Witherel CE, Yu T, Concannon M, et al. Immunomodulatory effects of human cryopreserved viable amniotic membrane in a pro-inflammatory environment in vitro. Cell Mol Bioeng. 2017;10:451–462.
  • Hortensius RA, Ebens JH, Harley BA. Immunomodulatory effects of amniotic membrane matrix incorporated into collagen scaffolds. J Biomed Mater Res A. 2016;10:1332–1342.
  • Kinoshita K, Satoh K, Sakamoto S. Human amniotic membrane and prostaglandin biosynthesis. Biol Res Pregnancy Perinatol. 1984;5:61–67.
  • Ho ATV, Palla AR, Blake MR, et al. Prostaglandin E2 is essential for efficacious skeletal muscle stem-cell function, augmenting regeneration and strength. Proc Natl Acad Sci U S A. 2017;114:6675–6684.
  • Coulson-Thomas VJ, Lauer ME, Soleman S, et al. Tumor necrosis factor-stimulated gene-6 (TSG-6) is constitutively expressed in adult central nervous system (CNS) and associated with astrocyte-mediated glial scar formation following spinal cord injury. J Biol Chem. 2016;291:19939–19952.
  • Zhang S, He H, Day AJ, et al. Constitutive expression of inter-α-inhibitor (IαI) family proteins and tumor necrosis factor-stimulated gene-6 (TSG-6) by human amniotic membrane epithelial and stromal cells supporting formation of the heavy chain-hyaluronan (HC-HA) complex. J Biol Chem. 2012;287:12433–12444.
  • Bischoff M, Stachon T, Seitz B, et al. Curr growth factor and interleukin concentrations in amniotic membrane-conditioned medium. Eye Res. 2017;42:174–180.
  • Leibinger M, Müller A, Gobrecht P, et al. Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation. Cell Death Dis. 2013;25:e609.
  • Wahl AF, Wallace PM. Oncostatin M in the anti-inflammatory response. Ann Rheum Dis. 2001;60:75–80.
  • Natesh K, Bhosale D, Desai A, et al. Oncostatin-M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling. Neoplasia. 2015;17:225–237.
  • Modaresifar K, Azizian S, Zolghadr M, et al. The effect of cryopreservation on anti-cancer activity of human amniotic membrane. Cryobiology. 2017;74:61–67.
  • Niknejad H, Khayat-Khoei M, Peirovi H, et al. Human amniotic epithelial cells induce apoptosis of cancer cells: a new anti-tumor therapeutic strategy. Cytotherapy. 2014;16:33–40.
  • Bu S, Zhang Q, Wang Q, et al. Human amniotic epithelial cells inhibit growth of epithelial ovarian cancer cells via TGF‑β1-mediated cell cycle arrest. Int J Oncol. 2017;51:1405–1414.
  • Novosel EC, Kleinhans C, Kluger PJ. Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev. 2011;63:300–311.
  • Schultheiss D, Gabouev AI, Cebotari S, et al. Biological vascularized matrix for bladder tissue engineering: matrix preparation, reseeding technique and short-term implantation in a porcine model. J Urol. 2005;173:276–280.
  • Moon JJ, West JL. Vascularization of engineered tissues: approaches to promoteangio- genesis in biomaterials. Curr Top Med Chem. 2008;8:300–310.
  • Burgos H. Angiogenic and growth factors in human amnio-chorion and placenta. Eur J Clin Invest. 1983;13:289–296.
  • Duan-Arnold Y, Uveges TE, Gyurdieva A, et al. Angiogenic potential of cryopreserved amniotic membrane is enhanced through retention of all tissue components in their native state. Adv Wound Care. 2015;4:513–522.
  • Niknejad H, Yazdanpanaha G. Opposing effect of amniotic membrane on angiogenesis originating from amniotic epithelial cells. J Med Hyp. 2014;8:39–41.
  • Peirovi H, Rezvani N, Hajinasrollah M, et al. Implantation of amniotic membrane as a vascular substitute in the external jugular vein of juvenile sheep. J Vasc Surg. 2012;56:1098–1104.
  • Qureshi IZ, Fareeha A, Khan WA. Technique for processing and preservation of human amniotic membrane for ocular surface reconstruction. World Acad Sci Eng Technol. 2010;69:763–766.
  • Hettiarachchi D, Dissanayake VH, Goonasekera HW. Optimizing amniotic membrane tissue banking protocols for ophthalmic use. Cell Tissue Bank. 2016 Sep;17(3):387–397.
  • [cited 2018 Dec 12]. Available from: https://www.fda.gov/biologicsbloodvaccines/tissuetissueproducts/regulationoftissues/ucm150485.htm
  • Brantley JN, Verla TD. Use of placental membranes for the treatment of chronic diabetic foot ulcers. Adv Wound Care (New Rochelle). 2015 Sep 1;4(9):545–559.
  • [cited 2018 Dec 12]. Available from:https://www.ema.europa.eu/en/human-regulatory/research-development
  • [cited 2018 Dec 12]. Available from: https://www.fda.gov/BiologicsBloodVaccines/TissueTissueProducts/RegulationofTissues/default.htm
  • [cited 2018 Dec 12]. Available from: https://asean.org/?static_post=asean-common-technical-dossier-actd
  • Füst A, Pállinger E, Stündl A, et al. Both freshly prepared and frozen-stored amniotic membrane cells express the complement inhibitor CD59. Scientific World J. 2012;2012:815615.
  • Hettiarachchi D, Dissanayake VH, Goonasekera HW. Optimizing amniotic membrane tissue banking protocols for ophthalmic use. Cell Tissue Bank. 2016;17:387–397.
  • Shimazaki J, Aiba M, Goto E, et al. Transplantation of human limbal epithelium cultivated on amniotic membrane for the treatment of severe ocular surface disorders. Ophthalmology. 2002;109:1285–1290.
  • Heikh ES, Sheikh ES, Fetterolf DE. Use of dehydrated human amniotic membrane allografts to promote healing in patients with refractory non healing wounds. Int Wound J. 2014;11:711–717.
  • McQuilling JP, Vines JB, Kimmerling KA, et al. Proteomic comparison of amnion and chorion and evaluation of the effects of processing on placental membranes. Wounds. 2017;29:E38–E42.
  • Lei J, Priddy LB, Lim JJ, et al. Identification of extracellular matrix components and biological factors in micronized dehydrated human amnion/chorion membrane. Adv Wound Care (New Rochelle). 2017;1:43–53.
  • [cited 2018 Dec 12]. Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/InternationalActivities/UCM273196.htm08/18
  • Morris MC, Baquero A, Redovan E, et al. Urolithiasis on absorbable and non-absorbable suture materials in the rabbit bladder. J Urol. 1986;135:602–603.
  • Utheim TP, Aass Utheim Ø, Salvanos P, et al. Concise review: altered versus unaltered amniotic membrane as a substrate for limbal epithelial cells. Stem Cells Transl Med. 2018;7:415–427.
  • Adamowicz J, Pokrywczynska M, Van Breda SV, et al. Concis review: tissue engineering of urinary bladder; we still have a long way to go? Stem Cells Transl Med. 2017;62:2033–2043.
  • Hansen MH, Hayn M, Murray P. The use of bowel in urologic reconstructive surgery. Surg Clin North Am. 2016;96:567–582.
  • Buscarini M, Pasin E, Stein JP. Complications of radical cystectomy. Minerva Urol Nefrol. 2007;59:67–87.
  • van Hemelrijck M, Thorstenson A, Smith P, et al. Risk of in-hospital complications after radical cystectomy for urinary bladder carcinoma: population-based follow-up study of 7608 patients. BJU Int. 2013;112:1113–1120.
  • Kollhoff DM, Cheng EY, Sharma AK. Urologic applications of engineered tissue. Regen Med. 2011;6:757–765.
  • Wiesner C, Thüroff JW. Techniques for uretero-intestinal reimplantation. Curr Opin Urol. 2004;14:351–355.
  • Hu JC, O’Malley P, Chughtai B, et al. Comparative effectiveness of cancer control and survival after robot-assisted versus open radical prostatectomy. J Urol. 2017;197:115–121.
  • Morgan DM, Umek W, Guire K, et al. Urethral sphincter morphology and function with and without stress incontinence. J Urol. 2009;182:203–209.
  • Keren R, Shaikh N, Pohl H, et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics. 2015;136:13–21.
  • Keshtkar A, Keshtkar A, Lawford P. Cellular morphological parameters of the human urinary bladder (malignant and normal). Int J Exp Pathol. 2007;88:185–190.
  • Abrams GA, Murphy CJ, Wang ZY, et al. Ultrastructural basement membrane topography of the bladder epithelium. Urol Res. 2003;31:341–346.
  • Yates CC, Hebda P, Wells A. Skin wound healing and scarring: fetal wounds and regenerative restitution. Birth Defects Res C Embryo Today. 2012;96:325–333.
  • Balsara ZR, Li X. Sleeping beauty: awakening urothelium from its slumber. Am J Physiol Renal Physiol. 2017;312:732–743.
  • de Boer WI, Schuller AG, Vermey M, et al. Expression of growth factors and receptors during specific phases in regenerating urothelium after acute injury in vivo. Am J Pathol. 1994;145:1199–1207.
  • Papafotiou G, Paraskevopoulou V, Vasilaki E, et al. EKRT14 marks a subpopulation of bladder basal cells with pivotal role inregeneration and tumorigenesis. Nat Commun. 2016;20:119–124.
  • Kreft ME, Sterle M, Veranic P, et al. Urothelial injuries and the early wound healing response: tight junctions and urothelial cytodifferentiation. Histochem Cell Biol. 2005;123:529–539.
  • Vaegler M, Maurer S, Toomey P, et al. Tissue engineering inurothelium regeneration. Adv Drug Deliv Rev. 2015;82:64–68.
  • Pokrywczyńska M, Kloskowski T, Balcerczyk D, et al. Stem cells and differentiated cells differ in their sensitivity to urine in vitro. J Cell Biochem. 2018;119:2307–2319.
  • Adamowicz J, Kloskowski T, Tworkiewicz J, et al. Urine is a highly cytotoxic agent: does it influence stem cell therapies in urology? Transplant Proc. 2012;44:1439–1441.
  • Lee JN, Kang JK, Jeong SY, et al. Predictive value of cortical transit time on MAG3 for surgery in antenatally detected unilateral hydronephrosis caused by ureteropelvic junction stenosis. J Pediatr Urol. 2018;14:55–59.
  • Tasian G, Cunha G, Baskin L. Smooth muscle differentiation and patterning in the urinary bladder. Differentiation. 2010;80:106–117.
  • Sutherland RS, Baskin LS, Hayward SW, et al. Regeneration of bladder urothelium, smooth muscle, blood vessels and nerves into an acellular tissue matrix. J Urol. 1996;156:571–577.
  • Baskin LS, Hayward SW, Young PF, et al. Ontogeny of the rat bladder: smooth muscle and epithelial differentiation. Acta Anat. 1996;155:163–171.
  • Murphy-Ullrich JE, Poczatek M. Activation of latent TGF-β by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev. 2000;11:59–69.
  • Bilbao M, Spaniol A, Bearss J, et al. Histology surrounding cystotomy healing in a Sprague-Dawley rat model. Int Urogynecol J. 2014;25:97–101.
  • Rowlatt U. Intrauterine healing in a 20-week human fetus. Virchows Arch. 1979;381:353–361.
  • Suresh S, Jindal S, Duvuru P, et al. Fetal obstructive uropathy: impact of renal histopathological changes on prenatal interventions. Prenat Diagn. 2011;31:675–677.
  • Whitby DJ, Ferguson MW. The extracellular matrix of lip wounds in fetal, neonatal and adult mice. Development. 1991;112:651–668.
  • Lorenz HP, Lin RY, Longaker MT, et al. The fetal fibroblast: the effector cell of scarless fetal skin repair. Plast Reconstr Surg. 1995;96:1251–1259.
  • Longaker MT, Whitby DJ, Ferguson MW, et al. Adult skin wounds in the fetal environment heal with scar formation. Ann Surg. 1994;219:65–72.
  • Ogawa Y, He H, Mukai S, et al. Heavy chain-hyaluronan/pentraxin 3 from amniotic membrane suppresses inflammation and scarring in murine lacrimal gland and conjunctiva of chronic graft-versus-host disease. Sci Rep. 2017;7:490–495.
  • Meller D, Pauklin M, Thomasen H, et al. Amniotic membrane transplantation in the human eye. Dtsch Arztebl Int. 2011;108:243–248.
  • Tao H, Fan H. Implantation of amniotic membrane to reduce postlaminectomy epidural adhesions. Eur Spine J. 2009;18:1202–1212.
  • Parolini O, Souza-Moreira L, O’Valle F, et al. Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disorders. Arthritis Rheumatol. 2014;66:327–339.
  • Wolbank S, Hildner F, Redl H, et al. Impact of human amniotic membrane preparation on release of angiogenic factors. J Tissue Eng Regen Med. 2009;3:651–654.
  • Joshi S, Yang J, Wang Q, et al. 14-3-3ζ loss impedes oncogene-induced mammary tumorigenesis and metastasis by attenuating oncogenic signaling. Am J Cancer Res. 2017;7:1654–1664.
  • Wu HY, Baskin LS, Liu W, et al. Understanding bladder regeneration: smooth muscle ontogeny. J Urol. 1999;162:1101–1105.
  • Master VA, Wei G, Liu W, et al. Urothlelium facilitates the recruitment and trans-differentiation of fibroblasts into smooth muscle in acellular matrix. J Urol. 2003;170:1628–1632.
  • Jerman UD, Veranič P, Kreft ME. Amniotic membrane scaffolds enable the development of tissue-engineered urothelium with molecular and ultrastructural properties comparable to that of native urothelium. Tissue Eng Part C Methods. 2014;20:317–327.
  • Sharifiaghdas F, Naji M, Sarhangnejad R, et al. Comparing supportive properties of poly lactic-co-glycolic acid (PLGA), PLGA/collagen and human amniotic membrane for human urothelial and smooth muscle cells engineering. Urol J. 2014;12:81620–81628.
  • Sartoneva R, Haimi S, Miettinen S, et al. Comparison of a poly-L-lactide-co-ε-caprolactone and human amniotic membrane for urothelium tissue engineering applications. J R Soc Interface. 2011;8:671–677.
  • Lenko J. Therapy of urethral stenosis with amnion transplantation. Pol Tyg Lek. 1955;22:1124–1125.
  • Norris MA, Cohen MS, Warren MM, et al. Bladder reconstruction in rabbits with glutaraldehyde-stabilized amniotic membranes. Urology. 1982;19:631–635.
  • Iijima K, Igawa Y, Imamura T, et al. Transplantation of preserved human amniotic membrane for bladder augmentation in rats. Tissue Eng. 2007;13:513–524.
  • Adamowicz J, Juszczak K, Bajek A, et al. Morphological and urodynamic evaluation of urinary bladder wall regeneration: muscles guarantee contraction but not proper function–a rat model research study. Transplant Proc. 2012;44:1429–1434.
  • Adamowicz J, Pokrywczyńska M, Tworkiewicz J, et al. New amniotic membrane based biocomposite for future application in reconstructive urology. PLoS One. 2016;11:e0146012.
  • Barski D, Gerullis H, Ecke T, et al. Bladder reconstruction with human amniotic membrane in a xenograft rat model: a preclinical study. Int J Med Sci. 2017;14(4):310–318.
  • Shakeri S, Haghpanah A, Khezri A, et al. Application of amniotic membrane as xenograft for urethroplasty in rabbit. Int Urol Nephrol. 2009;41:895–901.
  • Wang F, Liu T, Yang L, et al. Urethral reconstruction with tissue-engineered human amniotic scaffold in rabbit urethral injury models. Med Sci Monit. 2014;26:2430–2438.
  • Wilshaw SP, Kearney JN, Fisher J. Production of an acellular amniotic membrane matrix for use in tissue engineering. Tissue Eng. 2006;12:2117–2129.
  • Güneş M, Altok M, Özmen Ö, et al. A novel experimental method for penile augmentation urethroplasty with a combination of buccal mucosa and amniotic membrane in a rabbit model. Urology. 2017;102:240–246.
  • Koziak A, Kania P, Marcheluk A, et al. Reconstruction of long ureteral obstructions using xenogenic acellular collagen membranes. Ann Transplant. 2004;9:18.
  • Koziak A, Salagierski M, Marcheluk A, et al. Early experience in reconstruction of long ureteral strictures with allogenic amniotic membrane. Int J Urol. 2007;14:607–610.
  • Brandt FT, Albuquerque CD, Lorenzato FR. Female urethral reconstruction with amnion grafts. Int J Surg Investig. 2000;1:409–414.
  • Koziak A, Marcheluk A, Dmowski T, et al. Reconstructive surgery of male urethra using human amniotic membranes (grafts) – first announcement. Ann Transplant. 2004;9:21–24.
  • Barski D, Gerullis H, Ecke T, et al. Repair of a vesico-vaginal fistula with amniotic membrane - Step 1 of the IDEAL recommendations of surgical innovation. Cent European J Urol. 2015;68(4):459–461.
  • Patel VR, Samavedi S, Bates AS, et al. Dehydrated human amnion/chorion membrane allograft nerve wrap around the prostatic neurovascular bundle accelerates early return to continence and potency following robot-assisted radical prostatectomy: propensity score-matched analysis. Eur Urol. 2015;67:977–979.
  • Ogaya-Pinies G, Palayapalam-Ganapathi H, Rogers T, et al. Can dehydrated human amnion/chorion membrane accelerate the return to potency after a nerve-sparing robotic-assisted radical prostatectomy? Propensity score-matched analysis. J Robot Surg. 2018;12:235–243.
  • Razdan S, Bajpai RR, Razdan S, et al. A matched and controlled longitudinal cohort study of dehydrated human amniotic membrane allograft sheet used as a wraparound nerve bundles in robotic-assisted laparoscopic radical prostatectomy: a puissant adjunct for enhanced potency outcomes ahead of print. J Robot Surg. 2018. doi:10.1007/s11701-018-0873-7.
  • McCulloch P, Altman DG, Campbell WB, et al. No surgical innovation without evaluation: the IDEAL recommendations. Lancet. 2009;374(9695):1105–1112.
  • Oottamasathien S, Hotaling JM, Craig JR, et al. Amniotic therapeutic biomaterials in urology: current and future applications [internet]. Transl Androl Urol. 2017;6:943–950.
  • [cited 2018 Mar 28]. Available from: https://clinicaltrials.gov

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.